Monday, July 28, 2014 8:23:51 PM
When I said significant news, news could be either good or bad. NNVC's batting record has been heavily weighted towards good news. Then, they do control PR's, much of the company news, and much of the content. NO NEWS has always been a factor in the PPS. During long periods of "no news", the PPS tends to suffer. I imagine this is not going to change going into the future. Although, institutional ownership will change dynamics somewhat. Institutions, do not hesitate to make phone calls or send emailed questions when in doubt about what is going on concerning their investments. I had a brief stint as a communications analyst in a major corporation, and I had to field these inquiries all the time.
From my own experience, NNVC (Dr. Seymour), has been very responsive to my questions. This is why I recommend some pertinent question be directed to the company. Then this board could benefit from the answer (or lack of), and not have to digest an open ended question.
Tricky, but the company, Dr. Seymour can only respond with information that is public knowledge or non impactful to PPS. So, I recommend anyone posing questions, do a little research first. Many answers to questions have already been provided by the company.
Sometimes I can read into how something is said and not just what is said. Dr. Seymour comes across as a very engaging and honest person. His enthusiasm towards the company is undeniable and authentic. Yes, I can be misreading him. But, I just call them as I see them.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM